U.S., July 30 -- ClinicalTrials.gov registry received information related to the study (NCT07732686) titled 'Analysis of Breath Volatile Organic Compounds Using Mass Spectrometry' on July 23.
Brief Summary: The purpose of this clinical trial is to evaluate whether volatile organic compound (VOC) signatures detected in the breath of patients with cancer can serve as a potential screening tool for the early detection of cancer.
Study Start Date: Oct., 2026
Study Type: OBSERVATIONAL
Condition:
Pancreas Cancer
Hepatocellular Carcinoma
Lung Cancer
Ovarian Cancer
Breast Cancer
Head and Neck Cancer
Colon Cancer
Bladder Cancer
Other Cancer
Intervention:
DEVICE: Proton Transfer Reaction Mass Spectrometry Analysis
This is a noninvasive interv...